SCHEMBL7586466

SCHEMBL7586466

CC(OC(=O)/C=C\C(=O)O)C1CO1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HCAR2 Q8TDS4 8/20 0.55
ALDH1A1 P00352 2/20 0.33
GAA P10253 1/20 0.33
ATM Q13315 1/20 0.33
TSHR P16473 2/20 0.32
TP53 P04637 1/20 0.32
EGLN1 Q9GZT9 1/20 0.32
EGLN3 Q9H6Z9 1/20 0.32
GABRP O00591 2/20 0.31
GABRD O14764 2/20 0.31
GABRA1 P14867 2/20 0.31
GABRB1 P18505 2/20 0.31
GABRG2 P18507 2/20 0.31
GABRB3 P28472 2/20 0.31
GABRA5 P31644 2/20 0.31
GABRA3 P34903 2/20 0.31
GABRA2 P47869 2/20 0.31
GABRB2 P47870 2/20 0.31
GABRA4 P48169 2/20 0.31
GABRE P78334 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7599773 1.00 HCAR2 (0.55) HCAR2ALDH1A1GAAATMTSHR
SCHEMBL7657462 0.93 HCAR2 (0.42) HCAR2
SCHEMBL9858076 0.83 HCAR2 (0.52) HCAR2ALDH1A1GAAATMTSHR
SCHEMBL9858042 0.83 HCAR2 (0.52) HCAR2ALDH1A1GAAATMTSHR
Ammonia Solution, Strong SCHEMBL7016380 0.81 HCAR2 (0.46) HCAR2ALDH1A1GAAATMTSHR
Acrylic Acid SCHEMBL27635612 0.81 TSHR (0.35) HCAR2TSHR
SCHEMBL2120674 0.78 HCAR2 (0.46) HCAR2ATM
SCHEMBL10870459 0.78 TSHR (0.38) TSHR
SCHEMBL1504293 0.78 TSHR (0.38) TSHR
SCHEMBL1903351 0.77

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6495636-B2 A 3-(ETHYLENEOXYALKYLOXYALKYL)OXETANE AND DERIVATIVES; COPOLYMERIZED WITH A 1,1-DIFLUOROETHYLENE OR DERIVATIVE; VERY COMPATIBLE AND COPOLYMERIZABLE WITH UNSATURATED COMPOUNDS; WATERPROOFING; RADIATION TRANSPARENT JSR CORPORATION (JP) 2002-12-17 US disclosed
EP-0939090-B1 Graft copolymer and process for production thereof MITSUBISHI CHEM CORP (JP) 2002-09-18 EP disclosed
US-20010002423-A1 Oxetane compound, oxetane copolymer, and process for producing the oxetane compound SUGIYAMA NAOKI (JP) 2001-05-31 US disclosed
EP-1095938-A1 OXETANE COMPOUNDS, OXETANE COPOLYMER, AND PROCESS FOR PRODUCING OXETANE COMPOUNDS JSR Corporation (JP) 2001-05-02 EP disclosed
EP-0939090-A1 Graft copolymer and process for production thereof MITSUBISHI CHEMICAL CORPORATION (JP) 1999-09-01 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20010002423-A1 Oxetane compound, oxetane copolymer, and process for producing the oxetane compound OXER1, PYM1, AFF1 HCAR2 3429/4885ALDH1A1 1653/4885GAA 4803/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.